
RETA2-35
Prefilled Klik-Pen
RETAKLIK 2.0 combines Retatrutide 30mg and Cagrilintide 5mg in a single prefilled Klik-pen for multi-pathway metabolic research.
Retatrutide + CagrilintideRETAKLIK 2.0 is an advanced combination pen containing Retatrutide (30mg) and Cagrilintide (5mg) in 2.4ml solution. This combination targets four distinct metabolic receptors: GIP, GLP-1, Glucagon (via retatrutide), and Amylin (via cagrilintide). The quad-receptor approach represents the cutting edge of metabolic research, potentially offering additive effects on appetite suppression, energy expenditure, and glucose homeostasis beyond triple agonism alone.
All products are sold strictly for research and laboratory use only. Not for human consumption. By purchasing, you agree to use these products only for legitimate research purposes.